Subpopulations (%)

Patients with embryonic RMS

Control group

Р

CD3+ HLADR+

40.6 ± 7.4 (n = 9)

12.5 ± 2.0 (n = 12)

0.001

CD8+ HLADR+

38.6 ± 6.2 (n = 5)

8.9 ± 1.4 (n = 11)

0.000

Leu8+ CD4+

12.6 ± 3.3 (n = 5)

33.5 ± 4.7 (n = 10)

0.011

γδTCR

15.5 ± 1.5 (n = 6)

9.6 ± 1.5 (n = 10)

0.020